COI changes at NIH?

The National Institutes of Health is suggesting reducing the minimum financial conflict of interest that must be disclosed, among other changes to its conflict policy, the agency announced this morning at a teleconference. Image: Wikimedia commons, King of HeartsIf the changes are accepted, the minimum financial conflict that must be reported to the agency will be lowered from $10,000 to $5,000. "Clearly the way in which science is moving forward, in order to be successful, partnerships betwee

Written byJef Akst
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The National Institutes of Health is suggesting reducing the minimum financial conflict of interest that must be disclosed, among other changes to its conflict policy, the agency announced this morning at a teleconference.
Image: Wikimedia commons,
King of Hearts
If the changes are accepted, the minimum financial conflict that must be reported to the agency will be lowered from $10,000 to $5,000. "Clearly the way in which science is moving forward, in order to be successful, partnerships between NIH-funded researchers in industry are essential," said NIH director Francis Collins. "We believe that it is essential to tighten up this situation to be sure we are obtaining and maintaining the public trust and the integrity of the scientific enterprise." Other proposed changes include making the institution responsible for recognizing and reporting conflicts of interest, as opposed to the investigator. In addition, institutions would be required to develop a publicly accessible website to report significant financial conflicts of interest among the faculty. The proposed changes will be published in the Federal Register tomorrow (May 21), and will be open for public comment for 60 days before the changes are finalized.
**__Related stories:__***linkurl:FDA floats new conflict policy;http://www.the-scientist.com/blog/display/57373/
[22nd April 2010]*linkurl:Med journals adopt disclosure rules;http://www.the-scientist.com/blog/display/56057/
[14th October 2009]*linkurl:Conflicts of interest at Federal agencies;http://www.the-scientist.com/news/display/24056/
[24th July 2006]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform